Ugo Testa

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 32

Top Topics

Acute Myeloid Leukemia

Dna Methylation

Cancer Stem Cells

Top Venues

Current oncology (Toronto, Ont.)

International journal of molecular sciences

Technology in cancer research & treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Ugo Testa, Germana Castelli, Elvira Pelosi
CAR-T Cells in the Treatment of Nervous System Tumors. Cancers 16 (16) (2024)
Ugo Testa, Germana Castelli, Elvira Pelosi
CAR-T Cells in the Treatment of Nervous System Tumors. Cancers 16 (16) (2024)
Ugo Testa, Elvira Pelosi, Germana Castelli
Cholangiocarcinoma: Molecular Abnormalities and Cells of Origin. Technology in cancer research & treatment 22 (2023)
Ugo Testa, Germana Castelli, Elvira Pelosi
The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies. Current oncology (Toronto, Ont.) 30 (1) (2023)
Ugo Testa, Elvira Pelosi, Germana Castelli
Cholangiocarcinoma: Molecular Abnormalities and Cells of Origin. Technology in cancer research & treatment 22 (2023)
Gianfranco Catalano, Alessandra Zaza, Cristina Banella, Elvira Pelosi, Germana Castelli, Elisabetta de Marinis, Ariela Smigliani, Serena Travaglini, Tiziana Ottone, Mariadomenica Divona, Maria Ilaria Del Principe, Francesco Buccisano, Luca Maurillo, Emanuele Ammatuna, Ugo Testa, Clara Nervi, Adriano Venditti, Maria Teresa Teresa Voso, Nelida Inés Noguera
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients. Leukemia (2023)
Ugo Testa, Elvira Pelosi, Germana Castelli
Genetic, Phenotypic, and Clinical Heterogeneity of NPM1-Mutant Acute Myeloid Leukemias. Biomedicines 11 (7) (2023)
Ugo Testa, Elvira Pelosi, Germana Castelli
Cholangiocarcinoma: Molecular Abnormalities and Cells of Origin. Technology in cancer research & treatment 22 (2023)
Ugo Testa, Germana Castelli, Elvira Pelosi
Alk-rearranged lung adenocarcinoma: From molecular genetics to therapeutic targeting. Tumori (2023)
Germana Castelli, Mariantonia Logozzi, Davide Mizzoni, Rossella Di Raimo, Annamaria Cerio, Vincenza Dolo, Luca Pasquini, Maria Screnci, Tiziana Ottone, Ugo Testa, Stefano Fais, Elvira Pelosi
Ex Vivo Anti-Leukemic Effect of Exosome-like Grapefruit-Derived Nanovesicles from Organic Farming-The Potential Role of Ascorbic Acid. International journal of molecular sciences 24 (21) (2023)
Ugo Testa, Germana Castelli, Elvira Pelosi
The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies. Current oncology (Toronto, Ont.) 30 (1) (2023)
Ugo Testa, Germana Castelli, Elvira Pelosi
The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies. Current oncology (Toronto, Ont.) 30 (1) (2023)
Elvira Pelosi, Germana Castelli, Ugo Testa
CD123 a Therapeutic Target for Acute Myeloid Leukemia and Blastic Plasmocytoid Dendritic Neoplasm. International journal of molecular sciences 24 (3) (2023)
Ugo Testa, Germana Castelli, Elvira Pelosi
The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies. Current oncology (Toronto, Ont.) 30 (1) (2023)
Ugo Testa, Elvira Pelosi, Germana Castelli
Cholangiocarcinoma: Molecular Abnormalities and Cells of Origin. Technology in cancer research & treatment 22 (2023)
Elvira Pelosi, Germana Castelli, Ugo Testa
CD123 a Therapeutic Target for Acute Myeloid Leukemia and Blastic Plasmocytoid Dendritic Neoplasm. International journal of molecular sciences 24 (3) (2023)
Elvira Pelosi, Germana Castelli, Ugo Testa
CD123 a Therapeutic Target for Acute Myeloid Leukemia and Blastic Plasmocytoid Dendritic Neoplasm. International journal of molecular sciences 24 (3) (2023)
Elvira Pelosi, Germana Castelli, Ugo Testa
CD123 a Therapeutic Target for Acute Myeloid Leukemia and Blastic Plasmocytoid Dendritic Neoplasm. International journal of molecular sciences 24 (3) (2023)
Ugo Testa, Germana Castelli, Elvira Pelosi
The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies. Current oncology (Toronto, Ont.) 30 (1) (2023)
Cristina Banella, Gianfranco Catalano, Serena Travaglini, Elvira Pelosi, Tiziana Ottone, Alessandra Zaza, Gisella Guerrera, Daniela Francesca Angelini, Pasquale Niscola, Mariadomenica Divona, Luca Battistini, Maria Screnci, Emanuele Ammatuna, Ugo Testa, Clara Nervi, Maria Teresa Teresa Voso, Nelida Ines Noguera
Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment. Cancers 14 (10) (2022)
Ugo Testa, Germana Castelli, Elvira Pelosi
Genetic Alterations of Metastatic Colorectal Cancer. Biomedicines 8 (10) (2020)
Ugo Testa, Elvira Pelosi, Germana Castelli
Genetic Alterations in Renal Cancers: Identification of The Mechanisms Underlying Cancer Initiation and Progression and of Therapeutic Targets. Medicines (Basel, Switzerland) 7 (8) (2020)
Ugo Testa, Germana Castelli, Elvira Pelosi
Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias. Cancers 12 (9) (2020)
Ugo Testa, Germana Castelli, Elvira Pelosi
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications. Medicines (Basel, Switzerland) 6 (3) (2019)
Germana Castelli, Elvira Pelosi, Ugo Testa
Emerging Therapies for Acute Myelogenus Leukemia Patients Targeting Apoptosis and Mitochondrial Metabolism. Cancers 11 (2) (2019)
Ugo Testa, Germana Castelli, Elvira Pelosi
Genetic Abnormalities, Clonal Evolution, and Cancer Stem Cells of Brain Tumors. Medical sciences (Basel, Switzerland) 6 (4) (2018)
Ugo Testa, Elvira Pelosi, Germana Castelli
Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. Medical sciences (Basel, Switzerland) 6 (2) (2018)
Ugo Testa, Eleonora Petrucci, Luca Pasquini
Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells. Medicines (Basel, Switzerland) 5 (1) (2018)
Ugo Testa, Germana Castelli, Elvira Pelosi
Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells. Cancers 10 (8) (2018)
Ugo Testa, Germana Castelli, Elvira Pelosi
Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells. Medical sciences (Basel, Switzerland) 5 (4) (2017)
Ugo Testa, Elvira Pelosi, Germana Castelli, Catherine Labbaye
miR-146 and miR-155: Two Key Modulators of Immune Response and Tumor Development. Non-coding RNA 3 (3) (2017)
Elvira Pelosi, Germana Castelli, Ugo Testa
Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells. Biomedicines 5 (4) (2017)